高压氧联合阿司匹林降低脑梗死再发的临床研究  

Clinical study of hyperbaric oxygen combined with aspirin in the treatment of recurrent cerebral infarction

作　　者：林永丽[1] 陈森钦[1] 李春福[1] 

机构地区：[1]广东省信宜市人民医院高压氧科,广东信宜525300

出　　处：《中国医药科学》2017年第4期160-162,共3页China Medicine And Pharmacy

摘　　要：目的探讨阿司匹林联合高压氧预防脑梗再发的临床价值。方法将2014年1月~2016年6月就诊于本院的50例脑梗患者随机分为对照组与观察组各25例。对照组患者给予阿司匹林治疗,观察组在对照组治疗上给予高压氧治疗,观察两组患者脑梗的再发情况。结果 NIHSS和ADL评分结果表明患者在阿司匹林治疗基础上加以进行高压氧的疗程后,效果均明显提高,观察组与对照组相比差异具有统计学意义(P<0.05)。同时体现在治疗效果评估上,在显效方面,即患者功能基本恢复正常,其改善率为70%~90%的区间范围内,差异具有统计学意义(P<0.05)。结论阿司匹林联合高压氧预防脑梗再发优于单用阿司匹林,值得临床推广应用。Objective To explore the clinical value of hyperbaric oxygen combined with aspirin in the treatment of recurrent cerebral infarction. Methods 50 cases of patients with cerebral infarction cured in our hospital from January 2014 to June 2016 were selected and randomly divided into control group and observation group with 25 cases in each. Patient in control group were treated with aspirin, and patients in observation group were treated with hyperbaric oxygen on the basis of control group. The recurrence of cerebral infarction of the two groups were compared. Results The results of NIHSS and ADL showed that the effect of hyperbaric oxygen treatment on the basis of aspirin treatment was significantly improved. And the observation group compared with the control group, there was significant difference（P 〈 0.05）. At the same time, reflected in the evaluation of therapeutic effect, in terms of effectiveness, the function of the patients almost returned to normal, and the improvement rate was within the range of 70%-90%, and difference has statistical significanee（P 〈 0.05）. Conclusion The recurrence of hyperbaric oxygen combined with aspirin in the treatment of recurrent cerebral infarction is better than aspirin alone. It is worthy of promotion and application.

关 键 词：高压氧 阿司匹林 脑梗塞再发 联合 

分 类 号：R743.3[医药卫生—神经病学与精神病学]